Lung Cancer
Volume 69, Issue 3 , Pages 289-295 , September 2010

Snail nuclear expression parallels higher malignancy potential in neuroendocrine lung tumors

  • J.A. Galván

      Affiliations

    • Laboratorio del Banco de Tumores, Instituto Universitario de Oncología del Principado de Asturias, Obra Social CajAstur (IUOPA), c/Celestino Villamil s/n, 33006 Oviedo, Asturias, Spain
    • ,
  • M.V. González

      Affiliations

    • Oncologia Quirúrgica, Instituto Universitario de Oncologia del Principado de Asturias, Obra Social CajAstur (IUOPA), c/Celestino Villamil s/n, 33006 Oviedo, Asturias, Spain
    • ,
  • G. Crespo

      Affiliations

    • Servicio de Oncología Médica, Hospital Universitario Central de Asturias, 33006 Oviedo, Spain
    • ,
  • M.V. Folgueras

      Affiliations

    • Servicio de Anatomia Patológica, Hospital Universitario Central de Asturias, 33006 Oviedo, Spain
    • ,
  • A. Astudillo

      Affiliations

    • Laboratorio del Banco de Tumores, Instituto Universitario de Oncología del Principado de Asturias, Obra Social CajAstur (IUOPA), c/Celestino Villamil s/n, 33006 Oviedo, Asturias, Spain
    • Servicio de Anatomia Patológica, Hospital Universitario Central de Asturias, 33006 Oviedo, Spain
    • Corresponding Author InformationCorresponding author at: Servicio de Anatomía Patológica, Hospital Universitario Central de Asturias, 33006 Oviedo, Spain. Tel.: +34 985107891.

Received 24 September 2009 ,Revised 9 December 2009 ,Accepted 18 December 2009.

References 

  1. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. WHO classification of tumors: pathology and genetics of tumors of the lung, pleura, thymus and heart. Lyon: IARC Press; 2004;
  2. Loy TS, Darkow GV, Quesenberry JT. Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas. An immunohistochemical study with ultrastructural correlations. Am J Surg Pathol. 1995;19:173–182
  3. Capella C, Heitz PU, Hofler H, Solcia E, Kloppel G. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch. 1995;425:547–560
  4. Takeichi M. Morphogenetic roles of classic cadherins. Curr Opin Cell Biol. 1995;7:619–627
  5. Polakis P. Wnt signaling and cancer. Genes Dev. 2000;14:1837–1851
  6. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science. 2004;303:1483–1487
  7. Clavel CE, Nollet F, Berx G, Tejpar S, Nawrocki-Raby B, Kaplan HH, et al. Expression of the E-cadherin–catenin complex in lung neuroendocrine tumours. J Pathol. 2001;194:20–26
  8. Pelosi G, Scarpa A, Puppa G, Veronesi G, Spaggiari L, Pasini F, et al. Alteration of the E-cadherin/beta-catenin cell adhesion system is common in pulmonary neuroendocrine tumors and is an independent predictor of lymph node metastasis in atypical carcinoids. Cancer. 2005;103:1154–1164
  9. Shimazui T, Schalken JA, Giroldi LA, Jansen CF, Akaza H, Koiso K, et al. Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and P120cas) in bladder tumors. Cancer Res. 1996;56:4154–4158
  10. Kase S, Sugio K, Yamazaki K, Okamoto T, Yano T, Sugimachi K. Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res. 2000;6:4789–4796
  11. Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W, et al. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer. 1996;69:184–189
  12. Kalluri R, Neilson EG. Epithelial–mesenchymal transition and its implications for fibrosis. J Clin Invest. 2003;112:1776–1784
  13. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial–mesenchymal transition during tumor progression. Curr Opin Cell Biol. 2005;17:548–558
  14. Zeisberg M, Neilson EG. Biomarkers for epithelial–mesenchyma transitions. J Clin Invest. 2009;119:1429–1437
  15. Kalluri R, Weinberg RA. The basics of epithelial–mesenchyma transition. J Clin Invest. 2009;119:1420–1428
  16. Hay ED, Zuk A. Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced. Am J Kidney Dis. 1995;26:678–690
  17. Nieto MA, Sargent MG, Wilkinson DG, Cooke J. Control of cell behavior during vertebrate development by slug, a zinc finger gene. Science. 1994;264:835–839
  18. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. The transcription factor snail controls epithelial–mesenchyma transitions by repressing E-cadherin expression. Nat Cell Biol. 2000;2:76–83
  19. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000;2:84–89
  20. Peinado H, Portillo F, Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. Int J Dev Biol. 2004;48:365–375
  21. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol. 2002;3:155–166
  22. del Barrio MG, Nieto MA. Overexpression of snail family members highlights their ability to promote chick neural crest formation. Development. 2002;129:1583–1593
  23. Cheng CW, Wu PE, Yu JC, Huang CS, Yue CT, Wu CW, et al. Mechanisms of inactivation of E-cadherin in breast carcinoma: modification of the two-hit hypothesis of tumor suppressor gene. Oncogene. 2001;20:3814–3823
  24. Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J, et al. Correlation of snail expression with histological grade and lymph node status in breast carcinomas. Oncogene. 2002;21:3241–3246
  25. Poser I, Dominguez D, de Herreros AG, Varnai A, Buettner R, Bosserhoff AK. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor snail. J Biol Chem. 2001;276:24661–24666
  26. Sugimachi K, Tanaka S, Kameyama T, Taguchi K, Aishima S, Shimada M, et al. Transcriptional repressor snail and progression of human hepatocellular carcinoma. Clin Cancer Res. 2003;9:2657–2664
  27. Kuphal S, Palm HG, Poser I, Bosserhoff AK. Snail-regulated genes in malignant melanoma. Melanoma Res. 2005;15:305–313
  28. Travis WD, Brambilla E, MÜller-Hermelink HK, Harris CC. World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Lug, Pleura, Thymus and Hearth IARC Press, Lyon 2004.
  29. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal Biochem. 1987;162:156–159
  30. Franci C, Gallen M, Alameda F, Baro T, Iglesias M, Virtanen I, et al. Snail1 protein in the stroma as a new putative prognosis marker for colon tumours. PLoS One. 2009;4:e5595
  31. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, et al. E-cadherin-mediated cell–cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 1991;113:173–185
  32. Shimoyama Y, Hirohashi S, Hirano S, Noguchi M, Shimosato Y, Takeichi M, et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res. 1989;49:2128–2133
  33. Wijnhoven BP, Dinjens WN, Pignatelli M. E-cadherin–catenin cell–cell adhesion complex and human cancer. Br J Surg. 2000;87:992–1005
  34. Papkoff J. Regulation of complexed and free catenin pools by distinct mechanisms. Differential effects of Wnt-1 and V-Src. J Biol Chem. 1997;272:4536–4543
  35. Salon C, Moro D, Lantuejoul S, Brichon Py P, Drabkin H, Brambilla C, et al. E-cadherin–beta-catenin adhesion complex in neuroendocrine tumors of the lung: a suggested role upon local invasion and metastasis. Hum Pathol. 2004;35:1148–1155
  36. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta. 2003;1653:1–24
  37. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci. 1999;24:73–76
  38. Vleminckx K, Vakaet L, Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 1991;66:107–119
  39. Elloul S, Elstrand MB, Nesland JM, Trope CG, Kvalheim G, Goldberg I, et al. Snail, Slug, and Smad-Interacting Protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer. 2005;103:1631–1643
  40. Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R, et al. Differential expression of the epithelial–mesenchyma transition regulators Snail, Sip1, and Twist in gastric cancer. Am J Pathol. 2002;161:1881–1891
  41. Roy HK, Smyrk TC, Koetsier J, Victor TA, Wali RK. The transcriptional repressor Snail is overexpressed in human colon cancer. Dig Dis Sci. 2005;50:42–46
  42. Franci C, Takkunen M, Dave N, Alameda F, Gomez S, Rodriguez R, et al. Expression of Snail protein in tumor-stroma interface. Oncogene. 2006;25:5134–5144
  43. Rosivatz E, Becker KF, Kremmer E, Schott C, Blechschmidt K, Hofler H, et al. Expression and nuclear localization of Snail, an E-cadherin repressor, in adenocarcinomas of the upper gastrointestinal tract. Virchows Arch. 2006;448:277–287
  44. Nitadori J, Ishii G, Tsuta K, Yokose T, Murata Y, Kodama T, et al. Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel. Am J Clin Pathol. 2006;125:682–692
  45. Dasari V, Gallup M, Lemjabbar H, Maltseva I, McNamara N. Epithelial–mesenchyma transition in lung cancer: is tobacco the “Smoking Gun”?. Am J Respir Cell Mol Biol. 2006;35:3–9

PII: S0169-5002(09)00676-X

doi: 10.1016/j.lungcan.2009.12.010

Lung Cancer
Volume 69, Issue 3 , Pages 289-295 , September 2010

Article Tools

* Image Usage & Resolution